Miquel Vila Bover

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

Instituciones de las que forman parte

Jefe de grupo
Enfermedades Neurodegenerativas

Vall Hebron Institut de Recerca

Miquel Vila Bover

Instituciones de las que forman parte

Jefe de grupo
Enfermedades Neurodegenerativas

Vall Hebron Institut de Recerca

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder.

In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN).

I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.

Proyectos

Altered autophagy in Huntington's disease

IP: Miquel Vila Bover
Colaboradores: Marta Martínez Vicente, Laia Perez Lasarte
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 243000
Referencia: MS09/00184
Duración: 01/01/2010 - 31/12/2015

Inici, progressió i extensió de la Malaltia de Parkinson: rol de la neuromelanina, alfa-sinucleina i cossos de Lewy

IP: Miquel Vila Bover
Colaboradores: Laia Perez Lasarte
Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca
Financiación: 30000
Referencia: 2011FI_B 00575
Duración: 01/02/2011 - 31/01/2014

Inicio, progresión y extensión de la Enfermedad de Parkinson: rol de la neuromelanina, alfa-sinucleína y cuerpos de Levy

IP: Miquel Vila Bover
Colaboradores: -
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 197230
Referencia: PI10/00849
Duración: 01/01/2011 - 30/06/2014

Mecanismos de propagación y progresión de la enfermedad de Parkinson: rol de los cuerpos de Lewy

IP: Miquel Vila Bover
Colaboradores: Jordi Bove Badell
Entidad financiadora: Ministerio de Ciencia e Innovación-MICINN
Financiación: 35000
Referencia: SAF2009-06575-E
Duración: 05/03/2010 - 04/03/2011